Ariad Pharmaceuticals plunged after the company halted the most advanced trial of one of its cancer drugs. Ariad shares have lost three quarters of its value in the two weeks since the FDA placed a partial hold on new enrollments for all trials testing the drug.
Safeway traded higher after the company boosted its stock buyback by $2 billion.
Textron traded higher despite reporting third quarter profits that fell 31 percent on declining revenues. The world's largest maker of business aircraft also cut its full-year forecast.
Voxeljet more than doubled in value in its trading debut. The Germany based company is a maker of commercial 3D printers.
Alimera Sciences plummeted after the FDA rejected for a third time the company's eye implant device due to safety concerns. Shares of pSivida, which sold the rights to Iluvien to Alimera in 2005 but would get 20 percent of the profits, also plummeted.
Interpublic Group lost ground after the company reported lower than expected quarterly results due to weak demand in Europe. It also warned that the U.S. shutdown could hurt the current quarter.
Ingersoll Rand moved higher after the maker of Trane air-conditioners and Thermo King refrigeration units reported better-than-expected third-quarter results, thanks to rising demand for heating and cooling systems in a rebounding housing market.
AthenaHealth soared after reporting earnings. Sterne Agee raising its rating on the company to "buy" from "neutral."
—By CNBC's Rich Fisherman.
Questions? Comments? Email us at email@example.com